Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.
Two new supplier-diversity programs are launching in Indianapolis as local companies and other organizations try to make good on their equity promises from last year.
The engine maker confirmed Wednesday it is pushing its return-to-office timeline to early next year as COVID-19 infections and hospitalizations surge in Indiana and the nation.
According to a report by the Indiana Economic Development Corp., the Hoosier state ranks second nationally for worldwide life sciences exports and among the top five states for life sciences industry jobs.
Two former job applicants, aged 55 and 49, filed a proposed class-action lawsuit in U.S. District Court in Indianapolis on Wednesday, accusing the Indianapolis-based drug maker of age discrimination.
Roche Diagnostics is requiring COVID-19 vaccinations for all 8,000 people in its U.S. workforce, including about 4,500 in Indianapolis. Employees will have until Nov. 15 to get fully vaccinated, or will be terminated, the company said in a statement.
The sectors in central Indiana account for one out of every 10 jobs here, or 164,144 workers, and the jobs pay an average of $77,229, according to the report commissioned by BioCrossroads.
Eli Lilly and Co. has produced at least two video commercials featuring Olympic swimmer Ryan Murphy promoting its migraine treatment, Emgality. But one of the ads contains a fleeting disclaimer: Murphy doesn’t take Emgality.
She is sharp, funny, outspoken and, maybe most important, an advocate for the things she cares about—notably the advancement of women and people of color.
The not-for-profit’s strategy focused on community relationship-building and equity-oriented funding has other area groups rethinking their own procedures and how they share power with those they serve.
Eli Lilly and Co. passed up the chance to develop a vaccine and instead focused on making antibody treatments for patients who were already infected with the coronavirus. That turned out to be a financial whiff. Now all eyes will be on Lilly’s second-quarter earnings, which the company will release early Tuesday.
With COVID numbers on the rise and businesses taking steps to require masks or vaccinations, IBJ is collected tidbits here. Check back regularly for updates.
Eli Lilly and Co. confirmed to IBJ on Thursday its mask requirement is effective immediately and is based on recommendations earlier this week from the CDC. Many other large employers, however, are still in a wait-and-see mode on imposing new restrictions on employees.
Prominent businesses such as Eli Lilly and Co., Cummins Inc., Roche Diagnostics and Salesforce are among the Indiana companies that signed the letter urging passage of the Equality Act.
Even as some drugmakers, including Indianapolis-based Eli Lilly and Co., are pushing to get experimental drugs approved, federal regulators are still dealing with a huge blowback over the controversial way they reviewed a new Alzheimer’s drug by rival Biogen.
The Indianapolis-based drugmaker said the deal to buy Protomer Technologies could be worth up to $1 billion if the technology meets certain milestones. Lilly did not say how much it was paying up front in cash.
